サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1415460

代謝アッセイ市場：製品、技術、用途、エンドユーザー別-2024-2030年の世界予測

Metabolism Assays Market by Product (Assay Kits & Reagents, Instruments & Analyzers), Technology (Colorimetry, Fluorimetry, Spectrometry), Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
代謝アッセイ市場：製品、技術、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

代謝アッセイ市場規模は2023年に16億6,000万米ドルと推計され、2024年には17億8,000万米ドルに達し、CAGR 7.51%で2030年には27億6,000万米ドルに達すると予測されます。

代謝アッセイの世界市場

主な市場の統計
基準年[2023］ 16億6,000万米ドル
予測年[2024］ 17億8,000万米ドル
予測年 [2030] 27億6,000万米ドル
CAGR（%） 7.51%
代謝アッセイ Market-IMG1

代謝アッセイは、肝代謝に関連する化学構造の代謝安定性を同定するために使用されます。代謝アッセイは、細胞、組織、または生物全体で起こる生化学的プロセスを測定し定量化するために設計された分析技術です。これらのアッセイは、エネルギー産生、細胞成長、老廃物除去、環境ストレッサーへの応答など、多様な生物学的機能を制御する代謝経路に関する貴重な洞察を提供します。代謝アッセイは、創薬開発、毒物学研究、栄養分析、疾病診断、治療モニタリングなど、様々な研究分野において極めて重要です。心血管疾患（CVDs）、糖尿病、肥満、がんなどの生活習慣病が世界的に増加し続ける中、根本的な代謝異常を標的とした新規の治療介入の必要性が高まっています。個別化医療の採用が拡大し、研究活動が活発化していることが、市場の成長を後押しすると予想されます。しかし、先端技術や分析機器にかかるコストが高く、測定手順が標準化されていないことが、市場の需要を阻害する可能性があります。最先端技術の市場開拓と研究開発活動への投資の増加は、様々な生体系において代謝経路を高感度かつ高分解能で研究する能力を拡大し、代謝アッセイ市場に有利な機会をもたらしています。

地域別の洞察

南北南北アメリカは、生物医学研究に力を入れており、肥満や糖尿病などの代謝性疾患の有病率が高いことから、市場情勢に大きな影響を与えています。米国国立衛生研究所（NIH）は、身体活動がヒトの健康に分子レベルでどのように影響するかの理解を深めるために、代謝研究に投資しています。EMEA地域における代謝アッセイの需要を牽引しているのは、EU諸国です。欧州のバイオテクノロジー企業は、代謝アッセイに関連する特許を積極的に出願しており、欧州全域のライフサイエンス研究に対する政府資金援助は、代謝経路や代謝障害をよりよく理解するための数多くのイニシアチブにつながっています。アフリカと中東では、ヘルスケア・インフラへの投資が拡大しており、高度な代謝アッセイ診断技術の導入が進んでいます。APAC地域は、官民双方によるヘルスケア研究開発への投資の増加により、市場情勢が新興しています。さらに、政府は代謝性疾患の新規創薬標的を特定するための代謝性疾患研究支援プロジェクトを複数開始しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは代謝アッセイ市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、代謝アッセイ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-代謝アッセイ市場の市場規模および予測は？

2-代謝アッセイ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-代謝アッセイ市場における技術動向と規制の枠組みは？

4-代謝アッセイ市場における主要ベンダーの市場シェアは？

5-代謝アッセイ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の有病率が拡大し、正確な診断ソリューションの必要性が高まっている
      • 個別化医療への関心が世界中で高まっている
      • ヘルスケアインフラに対する政府の支援と資金提供
    • 抑制要因
      • 高度なアッセイ技術と機器のコストが高い
    • 機会
      • ハイスループットスクリーニング技術の開発とニーズの増加
      • 代謝アッセイ技術の継続的な進歩
    • 課題
      • 製品の承認に関する厳しい規制要件
  • 市場セグメンテーション分析
    • 製品：代謝アッセイで広範なデータ分析を提供する機器および分析装置
    • テクノロジー：費用対効果の高いソリューションとして測色を広範囲に活用
    • アプリケーション：代謝経路と薬剤標的を理解するための調査分野での代謝アッセイの採用の増加
    • エンドユーザー：製薬会社における創薬と開発のための代謝アッセイの重要な使用法
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 代謝アッセイ市場：製品別

  • アッセイキットおよび試薬
  • 計測器と分析装置

第7章 代謝アッセイ市場：技術別

  • 測色
  • 蛍光分析
  • 分光分析

第8章 代謝アッセイ市場：用途別

  • 診断
  • 調査

第9章 代謝アッセイ市場：エンドユーザー別

  • 学術調査機関
  • 診断研究所
  • 病院とクリニック
  • 製薬およびバイオテクノロジー企業

第10章 南北アメリカの代謝アッセイ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の代謝アッセイ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの代謝アッセイ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 新製品発売と機能強化
    • 受賞・表彰・拡大

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3H Biomedical AB
    • Abcam PLC
    • Abnova Corporation
    • Agilent Technologies, Inc.
    • AMSBIO
    • BioAssay Systems
    • BIOTREN
    • BMG LABTECH GmbH
    • BPS Bioscience, Inc.
    • Cayman Chemical Company
    • Chondrex, Inc.
    • Creative Bioarray
    • Elabscience Biotechnology Inc.
    • EMELCA Bioscience
    • Enzo Life Sciences, Inc.
    • Eton Bioscience, Inc.
    • Kaneka Eurogentec S.A.
    • Merck KGaA
    • Ncardia Services BV
    • NOVOCIB
    • Promega Corporation
    • RayBiotech Life, Inc.
    • Sartorius AG
    • Tempo Bioscience
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. METABOLISM ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. METABOLISM ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. METABOLISM ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. METABOLISM ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. METABOLISM ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. METABOLISM ASSAYS MARKET DYNAMICS
  • FIGURE 7. METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. METABOLISM ASSAYS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. METABOLISM ASSAYS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. METABOLISM ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. METABOLISM ASSAYS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. METABOLISM ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. METABOLISM ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL METABOLISM ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. METABOLISM ASSAYS MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. METABOLISM ASSAYS MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 9. METABOLISM ASSAYS MARKET SIZE, BY COLORIMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. METABOLISM ASSAYS MARKET SIZE, BY FLUORIMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. METABOLISM ASSAYS MARKET SIZE, BY SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. METABOLISM ASSAYS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. METABOLISM ASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. METABOLISM ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. METABOLISM ASSAYS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. METABOLISM ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. METABOLISM ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES METABOLISM ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA METABOLISM ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM METABOLISM ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM METABOLISM ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM METABOLISM ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM METABOLISM ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. METABOLISM ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. METABOLISM ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. METABOLISM ASSAYS MARKET LICENSE & PRICING
目次
Product Code: MRR-1730A405F98C

[199 Pages Report] The Metabolism Assays Market size was estimated at USD 1.66 billion in 2023 and expected to reach USD 1.78 billion in 2024, at a CAGR 7.51% to reach USD 2.76 billion by 2030.

Global Metabolism Assays Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.66 billion
Estimated Year [2024] USD 1.78 billion
Forecast Year [2030] USD 2.76 billion
CAGR (%) 7.51%
Metabolism Assays Market - IMG1

A metabolic assay is used to identify metabolic stability in chemical structures in connection with hepatic metabolism. Metabolism assays are analytical techniques designed to measure and quantify the biochemical processes occurring within cells, tissues, or whole organisms. These assays provide valuable insights into metabolic pathways that regulate diverse biological functions such as energy production, cell growth, waste removal, and response to environmental stressors. Metabolism assays are crucial in various research fields, including drug discovery and development, toxicology studies, nutrition analysis, disease diagnosis, and treatment monitoring. As the global incidence of lifestyle-related disorders such as cardiovascular diseases (CVDs), diabetes, obesity, and cancer continues to increase, there is an increasing need for novel therapeutic interventions targeting underlying metabolic abnormalities. Growing adoption of personalized medicine and rising research actions are expected to fuel the market growth. However, the High costs of advanced technologies and analytical instruments and the Lack of standardization in assay procedures may hamper the market demand. The ongoing development of cutting-edge technologies and rising investments in R&D activities have expanded the capabilities for studying metabolic pathways at high sensitivity and resolution across various biological systems, significantly creating a lucrative opportunity in the metabolism assay market.

Regional Insights

The Americas has a significant landscape in the metabolism assays market owing to its strong focus on biomedical research and a higher prevalence of metabolic diseases such as obesity and diabetes. The investment by the National Institutes of Health (NIH) in metabolic research to advance understanding of how physical activity affects human health at a molecular level. EU countries are key players in driving demand for metabolism assays within the EMEA region. European biotech companies have been actively filing patents related to metabolism assays; government funding for life science research across Europe has led to numerous initiatives to better understand metabolic pathways and disorders. In Africa and the Middle East, growing investments in healthcare infrastructure have led to increased adoption of advanced metabolism assay diagnostic techniques. The APAC region has a developing landscape in the metabolism assays market owing to increasing investment in healthcare R&D by both public and private entities. Moreover, the Government has initiated several metabolic disease research supporting projects to identify novel drug targets for metabolic diseases.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Metabolism Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Metabolism Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Metabolism Assays Market, highlighting leading vendors and their innovative profiles. These include 3H Biomedical AB, Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., AMSBIO, BioAssay Systems, BIOTREN, BMG LABTECH GmbH, BPS Bioscience, Inc., Cayman Chemical Company, Chondrex, Inc., Creative Bioarray, Elabscience Biotechnology Inc., EMELCA Bioscience, Enzo Life Sciences, Inc., Eton Bioscience, Inc., Kaneka Eurogentec S.A., Merck KGaA, Ncardia Services BV, NOVOCIB, Promega Corporation, RayBiotech Life, Inc., Sartorius AG, Tempo Bioscience, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Metabolism Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Assay Kits & Reagents
    • Instruments & Analyzers
  • Technology
    • Colorimetry
    • Fluorimetry
    • Spectrometry
  • Application
    • Diagnostics
    • Research
  • End User
    • Academic Research Institutes
    • Diagnostics Laboratories
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Metabolism Assays Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Metabolism Assays Market?

3. What are the technology trends and regulatory frameworks in the Metabolism Assays Market?

4. What is the market share of the leading vendors in the Metabolism Assays Market?

5. Which modes and strategic moves are suitable for entering the Metabolism Assays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Metabolism Assays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Escalating prevalence of chronic conditions with enahnced need for accurate diagnostic solutions
      • 5.1.1.2. Growing preference for personalized medicine worldwide
      • 5.1.1.3. Supportive government initiatives and funding for healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced assay technologies and equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing development and need for high-throughput screening techniques
      • 5.1.3.2. Ongoing advancements in metabolism assays techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements related to product approvals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Instruments & and analyzers providing extensive data analysis in metabolism assays
    • 5.2.2. Technology: Extensive utilization of colorimetry as a cost-effective solution
    • 5.2.3. Application: Rising adoption of metabolism assays in the research area for understanding metabolic pathways and drug targets
    • 5.2.4. End User: Vital use of metabolism assays in pharmaceutical companies for drug discovery and development
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Metabolism Assays Market, by Product

  • 6.1. Introduction
  • 6.2. Assay Kits & Reagents
  • 6.3. Instruments & Analyzers

7. Metabolism Assays Market, by Technology

  • 7.1. Introduction
  • 7.2. Colorimetry
  • 7.3. Fluorimetry
  • 7.4. Spectrometry

8. Metabolism Assays Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Research

9. Metabolism Assays Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Diagnostics Laboratories
  • 9.4. Hospitals & Clinics
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Metabolism Assays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Metabolism Assays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Metabolism Assays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. New Product Launch & Enhancement
      • 13.3.1.1. A new image-based cellular profiling tool peers deeply into metabolic biology
    • 13.3.2. Award, Recognition, & Expansion
      • 13.3.2.1. MU bags Indian patent for low-cost Colorimeter

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. 3H Biomedical AB
    • 14.1.2. Abcam PLC
    • 14.1.3. Abnova Corporation
    • 14.1.4. Agilent Technologies, Inc.
    • 14.1.5. AMSBIO
    • 14.1.6. BioAssay Systems
    • 14.1.7. BIOTREN
    • 14.1.8. BMG LABTECH GmbH
    • 14.1.9. BPS Bioscience, Inc.
    • 14.1.10. Cayman Chemical Company
    • 14.1.11. Chondrex, Inc.
    • 14.1.12. Creative Bioarray
    • 14.1.13. Elabscience Biotechnology Inc.
    • 14.1.14. EMELCA Bioscience
    • 14.1.15. Enzo Life Sciences, Inc.
    • 14.1.16. Eton Bioscience, Inc.
    • 14.1.17. Kaneka Eurogentec S.A.
    • 14.1.18. Merck KGaA
    • 14.1.19. Ncardia Services BV
    • 14.1.20. NOVOCIB
    • 14.1.21. Promega Corporation
    • 14.1.22. RayBiotech Life, Inc.
    • 14.1.23. Sartorius AG
    • 14.1.24. Tempo Bioscience
    • 14.1.25. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing